Share Name Share Symbol Market Type Share ISIN Share Description
Tate & Lyle LSE:TATE London Ordinary Share GB0008754136 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +1.50p +0.22% 668.50p 668.00p 668.50p 672.00p 665.50p 670.00p 1,518,257.00 14:17:28
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Food Producers 2,355.0 126.0 35.1 19.0 3,119.75

Tate & Lyle (TATE) Latest News

More Tate & Lyle News
Tate & Lyle Takeover Rumours

Tate & Lyle (TATE) Share Charts

1 Year Tate & Lyle Chart

1 Year Tate & Lyle Chart

1 Month Tate & Lyle Chart

1 Month Tate & Lyle Chart

Intraday Tate & Lyle Chart

Intraday Tate & Lyle Chart

Tate & Lyle (TATE) Discussions and Chat

Tate & Lyle Forums and Chat

Date Time Title Posts
17/11/201619:35Tate and Lyle Graph's and Charts2,816.00
03/7/201408:18Darren Sinden bullish on Tate & Lyle PLC live on TipTV-
10/9/201304:52TATE sweet & sour103.00
28/5/200913:09PRICE MANIPULATION IN ACTION27.00
30/9/200709:07TATE3.00

Add a New Thread

Tate & Lyle (TATE) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
14:17:23668.5060401.10AT
14:17:22668.507004,679.50AT
14:17:22668.502201,470.70AT
14:17:22668.5080534.80AT
14:17:20668.5041274.09AT
View all Tate & Lyle trades in real-time

Tate & Lyle (TATE) Top Chat Posts

DateSubject
05/12/2016
08:20
Tate & Lyle Daily Update: Tate & Lyle is listed in the Food Producers sector of the London Stock Exchange with ticker TATE. The last closing price for Tate & Lyle was 667p.
Tate & Lyle has a 4 week average price of 685.83p and a 12 week average price of 735.48p.
The 1 year high share price is 850p while the 1 year low share price is currently 529p.
There are currently 466,678,758 shares in issue and the average daily traded volume is 2,508,613 shares. The market capitalisation of Tate & Lyle is £3,119,747,497.23.
25/2/2016
21:44
wad collector: Mottley Fool 2 weeks ago ; Also reporting today was Tate & Lyle (LSE: TATE). Its shares are down by 6% despite it announcing that it’s performing in line with market expectations. Furthermore, it stated that its long-term outlook is bright even though short-term pressures remain in some of its divisions. For example, Tate & Lyle expects its speciality food ingredients division to operate in a market that grows at mid-single-digits, with its key aim being to grow modestly ahead of the market and deliver margin expansion. Meanwhile, in the company’s bulk ingredients division it continues to target stable earnings, with further weakness and volatility expected in its commodities division. With Tate & Lyle forecast to increase its earnings by 7% in the next financial year and currently yielding 5.2%, it appears to be a sound long-term buy. While its share price may be volatile in the short run, its long-term prospects remain encouraging.
28/10/2015
11:14
scallywagkid: Jefferies raises Tate price target to 660 (605)p with a 'Buy'
27/2/2015
09:58
wad collector: There is a remarkable similarity between the December share price dip and recovery and the February dip and recovery. I am no chartist but a continuation with a few hiccups to 650 or so would be the same pattern . (Ignoring the vulgar complication of actual logic or news)
19/2/2015
09:00
dendria: Canaccord Genuity states a potential bid from Bunge is now “substantially greater” given Tate & Lyle’s “lowered valuation, a strong U.S. dollar, low interest rates, a good strategic fit and shareholder dissatisfaction with Tate.” Canaccord Genuity moved its recommendation on Tate & Lyle from sell to buy and raised its target price to 650p from 530p. The analysts also modelled an acquisition of Tate & Lyle by Bunge at 781p a share, a 40% premium to the current share price. Source: bakingbusiness.com!
23/9/2014
08:11
housemartin2: Salpara views on Splenda seem IMV pretty correct. TATE is in my income portfolio so I am not concerned about share price movements in this stock over a 2 or 3 year period (but I do not obviously like showing a loss even if it is a paper one to me). My real concern comes over the security of the dividend (I think we are alright to date given existing cover and cash flow) and whether the Splenda market position is an existential threat to the long term survival of TATE. Obviously I do not or I would not be invested here but repeated bad news does move this up my concern table !
03/11/2011
11:56
craigends: That reports a nice sweetener for the share price. Getting back to old levels - and sound figures.
06/6/2011
08:17
wad collector: Presumably the market is not too excited by the bid rumour , judging by the muted further response.Sell into the rise?Or view as a long term hold for gradual capital gain? From 2/6/11 Independent A tasty takeover tale prompted investors to rediscover their appetite for Tate & Lyle last night, helping the food ingredients group to the top of the mid-tier index and its highest share price since 2007. The company powered up 31p to 651.5p on the back of vague speculation that a number of groups could be mulling over a potential bid worth between 820p and 850p a share. The commodities group Archer Daniels Midland was one of the names in the frame, the US giant having been linked with a move in similar talk earlier in the year. The sugar trader Bunge was also being discussed as a possible aggressor. However, market voices played down the mutterings, instead putting Tate's rise down to positive sentiment around the company following the release last week of its full-year figures. The update prompted Deutsche Bank, which described the results as "impressive", to raise its price target yesterday by 60p to 785p and reiterate its "buy" recommendation. The broker's analysts also welcomed Tate's plans to reopen its sucralose plant in the US as "great news", adding that "this decision alone could drive mid-single-digit profit growth... for years to come".
24/1/2010
19:14
jab118: TATE & LYLE The sweetener manufacturer has fingers in many pies, which gives it good diversity. Along with artificial sweeteners, it makes many other products including animal feed, sugar, jams and industrial starches. It is also one of the major suppliers of sweeteners to Coca-Cola and Pepsi. It appointed a new chief executive last October who has been conducting a review of the group. He could be the driving force in any changes, disposals or sales at the company. The share price hit a recent low last March at under 250p but has made a recovery and is currently just above 400p. Things did get a bit jittery with fears that sweetener prices have been falling which saw a slight dip this month. Back in the halcyon pre-credit-crisis days of January 2007, a bid of 1,000p a share was rumoured to be on the cards from a private equity firm. The share price then was more than 700p. Today it could be seen as a bargain for a cash-rich predator. EXPERT VIEW Phil Spencer, equity analyst at Brewin Dolphin, said: "Tate & Lyle was a pretty obvious target for private equity take-up and this is still the case. I think they'd like to get their hands on the group and break up the divisions and sell them off. And it's a very attractive dividend payer which intrigues people." THE NUMBERS Tate & Lyle has been offering impressive yields for many years while continuing to pay off its debts. Its current yield is 5.6pc while shares are trading at 9.8pc its 2011 expected earnings. But Credit Suisse cut its pre-tax profits forecast on Tate & Lyle for the year to March 2011 by £20m to £240m
04/3/2009
09:04
revoc2: hi guyz...im sure there r ppl here who have/know ppl in the city etc who will know what is going on wth tate share price? has no one here asked anyone in re to this? thanx
30/9/2008
20:51
wad collector: From the Times a week ago : Tate & Lyle share price caning an opportunity to buy back in Nick Hasell: Tempus Nearly a year to the day after last September's surprise profits warning, shares in Tate & Lyle – down 11 per cent yesterday – are under pressure again. This time it is not a cut to earnings forecasts that is unsettling the sugar and sweeteners producer, but the decision of an American judge. The initial ruling of the International Trade Commission (ITC) has been to dismiss Tate's claim that Chinese manufacturers exporting sucralose to America were infringing its patent over the high-intensity sweetener. That is worrying, given that the six-member ITC panel – who will make a final ruling in January – usually follow the judge's advice. It is also unfortunate that the sucralose setback comes less than a week after Tate brought forward its first-half trading update to disclose the departure of its finance director, above-forecast commissioning costs at a new mill in Tennessee, weak sugar prices and below-forecast launches of new US products containing sucralose. Tate has a near-monopoly on the production of sucralose, which, given its high margins, accounts for one fifth of group profits. So far, the output from generic competitors has been only one tenth of Tate's output – less than expected when Tate first launched its legal action. Tate's existing supply contracts and the fact that it would take about two years for a rival to begin volume production should protect short-term profitability. So, too, should its Splenda brand and the proven purity of its product – a consideration less lightly dismissed since the recall of contaminated Chinese baby milk. If there is a blow in yesterday's ruling, it is that Tate's longer-term shift towards "value-added" – as opposed to commoditised – ingredients is in danger of losing momentum. What is more compelling is Tate's scarcity value. Along with National Starch, now part of Akzo Nobel, it is one of the world's few remaining independent food ingredients producers. It also has an asset base that it would be prohibitively costly to replicate. It owns three of the ten biggest corn mills in America, all of which, being located in the Midwest, have critical access to raw materials and the US rail network. Further, after four years of heavy capital expenditure, Tate's investment in new plant is nearly complete. With Harbinger Capital having built a 19 per cent stake, it is not too fanciful to assume that the US hedge fund might add to its holding or push for consolidation – perhaps through a merger of Tate with Bunge, of the United States, where it is also a shareholder. Such a deal is unlikely to be blocked on antitrust grounds, given that a combined entity would be no bigger than Cargill or ADM, the industry heavyweights. Tempus advised readers to take profits in April at 543½p. At 369½p, or less than ten times current-year earnings and yielding nearly 7 per cent, it is time to buy back in.
Tate & Lyle share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V: D:20161205 14:32:56